A huge shout out 📢 to #oncology team at #SarawakGeneralHospital in #Kuching #Malaysia 🇲🇾 esp. Dr PJ Voon for being such gracious hosts to ASCO #AsiaPacific #RegionalCouncil these last 2 days! Super dedicated staff with lots of #meaningful initiatives taking place here!…

Our ASCO #AsiaPacific #RegionalCouncil meeting in #Kuching #Sarawak . Led by the amazingly energetic Melvin LK CHUA, I am glad to be part of this group helping shape #ASCO ’s engagement with members and planning specific #initiatives in our region. Kate Clarke 💉💉💉💉💉🚴 Diah Martina…

My first trip to Sarawak! Thanks to ASCO
APAC Regional Council started in 2019 has made several advances in #CancerCare in this region.
It started with the City Challenge in beautiful Kuching investing in Sarawak General Hospital David D. W. Lee

Nice to see us coming full…

Asian’s collective effort in reaching the consensus for the Advanced PCa Management ! Thank you Declan Murphy Ian Davis Edmund Chiong for your leadership! Advanced Prostate Cancer Consensus Conference HKSUO

What I learned in 🇨🇱 today … $5mill = one #radiotherapy machine☢️, can treat 10k patients. $5mill = 135 patients worth of trastuzumab. 🧐
The Lancet Oncology - tinyurl.com/6bry9a2a “an essential pillar in multi-D oncology…an inexpensive modality” - 👏🏽 well said Targeting Cancer

Last day to submit your abstracts to #ASCOBT24 !!

Lots of research awards for the top40 ranked abstracts and also Merit awards for trainees!

Junior faculty and trainees opportunities are also being lined up 😊

ASCO ASCOPres Lillian Siu

Submit an abstract by 11:59 PM ET April 9 for ASCOBT24 - Lillian Siu
ASCO Melvin LK CHUA
oncodaily.com/43901.html

#ASCO #ASCO BT24 #Cancer #OncoDaily #Oncology

#ASCOBT24 @asco Aug 8-10, 2024 in Yokohama, Japan. Chaired by the dynamic Melvin LK CHUA. Exciting agenda with relevant topics across disciplines. Submit abstract by 11:59 PM ET April 9.

Learn more ➡️ brnw.ch/21wI0V9

11 days to submit your abstracts for #ASCOBT24
Deadline 9 April 2024 US ET!

We are all inclusive for #CancerResearch
#CancerCare
#TranslationalResearch
#ClinicalTrials
#Innovation

Check out the amazing line-up of speakers! Lillian Siu ASCO
conferences.asco.org/breakthrough/p…

#ICHNO24

Honoured to deliver the Keynote lecture on ctDNA in #headandneckcancer

Thanks to great colleagues Eleni Rettig Linda Chen Nancy Lee who were generous to share their data and insights on the trials using ctDNA guided treatment and FU in #HPVOPSCC

Much to be learnt!

Limitations of ctDNA 🩸use in #HPV + #HNSCC : beware of false negs if low baseline ctDNA, can not be used for tx deescalation. Melvin LK CHUA on 🔥 #ICHNO2024

Spoiler alert! 🔴 #ICHNO24

University Health Network University of Toronto Prof Sophie Huang espousing on the integration of iENE in staging and risk stratification in #headandneckcancer

Great work by Christina Henson, MD Lachlan McDowell Head and Neck Cancer International Group

Expect it to be part of upcoming new staging editions! 😄

Excellent talk by Brigette Ma summarizing the progress over time in nasopharyngeal cancer treatment and current guidelines. At #ICHNO2024

Happening at #ICHNO24

Wonderful Keynote lecture by Prof_Brigette Ma CUHK Medicine on the changing landscape of #NPC #nasopharyngealcarcinoma

Nice summary of all the clinical and translational advances over the decades! Highlights the impressive number of RCTs over the years!

In the city of lights, we’re illuminating breakthrough innovations and research that are improving global cancer care today—and you need to be there to see it. Join us at ASCO Breakthrough in Yokohama, Japan.

Great hosting the team from University of Michigan this morning and showcasing our Precision Radiotherapeutic Oncology Programme

Thanks for visiting Daniel Chang! Hope you enjoy your rest of the time in 🇸🇬 Weather and food are great! 😜

#GlobalHealth
#Collaboration
#RadiationOncology

This is amazing!! Very very stoked for Lillian Siu
Who better person to lead AACR with its broad membership to be able to focus on all the needs of #CancerResearch from trials to translational-basic research to cost, Advance Care AND advocate for #Diversity

This is a massive and timely undertaking to push for a new stage classification in #NPC #nasopharyngealcarcinoma

Look out for the updated 9th ed staging in due course w Pierre Blanchard, MD

cell.com/cancer-cell/fu…

Check out the beautiful cover art!

'Large-Scale Whole-Exome Sequencing Association Study Implicates Genetic Effects on Viral Oncogenesis and TME in Nasopharyngeal Carcinoma' : Crucial interplay between genetic variations and essential elements of TME (EBV&non-cancer cells)
More at medrxiv.org/cgi/content/sh… #medRxiv

Speaking world tour of 3 countries, 5 cities in 11 days!!! In between running clinics and planning treatments! 😂😂

Didn’t imagine I wuld survive such a feat but Impt to showcase the work we do in #Nosecancer #NasopharyngealCancer at NCCS

Very thankful of my Team &Family!